ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $83.76 and traded as high as $99.29. ProShares Ultra Nasdaq Biotechnology shares last traded at $98.28, with a volume of 27,298 shares traded.
ProShares Ultra Nasdaq Biotechnology Price Performance
The company has a 50 day moving average of $83.76 and a two-hundred day moving average of $82.92. The company has a market capitalization of $91.40 million, a PE ratio of 20.68 and a beta of 1.24.
Hedge Funds Weigh In On ProShares Ultra Nasdaq Biotechnology
Several hedge funds and other institutional investors have recently modified their holdings of BIB. Franklin Resources Inc. bought a new position in shares of ProShares Ultra Nasdaq Biotechnology in the 2nd quarter worth approximately $32,000. Citadel Advisors LLC bought a new stake in ProShares Ultra Nasdaq Biotechnology during the third quarter valued at about $307,000. Finally, Kaizen Financial Strategies purchased a new stake in ProShares Ultra Nasdaq Biotechnology in the fourth quarter worth about $424,000.
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.
Featured Articles
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
